For example, prolyl hydroxylase domain enzymes (PHD), the classical Hypoxia Inducible Factor-1alpha (HIF-1α) hydroxylation-modifying enzymes under normoxia, have been identified as the critical targets of iron chelators that are clinically beneficial in many neurological disorders [50,51]. The gene discussed is HIF1A; the disease is nervous system disorder.